---
title: "Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions | HELP Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283351153.md"
description: "Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions | HELP Stock News"
datetime: "2026-04-20T04:15:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283351153.md)
  - [en](https://longbridge.com/en/news/283351153.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283351153.md)
generator: "portal-rs"
---

# Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions | HELP Stock News

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions | HELP Stock News

### Related Stocks

- [HELP.US](https://longbridge.com/en/quote/HELP.US.md)
- [CYBN.US](https://longbridge.com/en/quote/CYBN.US.md)

## Related News & Research

- [Cybin announces annual general and special shareholder meeting](https://longbridge.com/en/news/296336431.md)
- [Helus Pharma Fast-Tracks Phase 3 Enrollment for MDD Drug HLP003](https://longbridge.com/en/news/293390329.md)
- [Vidac Pharma board member Dr. Max Herzberg sells Vidac Pharma shares for EUR 6,450](https://longbridge.com/en/news/296702900.md)
- [Is Royalty Pharma (RPRX) Undervalued On Its $100 Million Zealand Pharma Royalty Deal?](https://longbridge.com/en/news/296647266.md)
- [Liminatus Pharma sets 1-for-50 reverse stock split effective Aug. 20](https://longbridge.com/en/news/296264260.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**